What does a double‑peaked P wave (P mitrale) on a 12‑lead ECG indicate and what is the recommended next step in evaluation and management?

Double-Peaked P Wave (P Mitrale)

A double-peaked P wave indicates left atrial abnormality and should prompt immediate echocardiographic evaluation to assess left atrial size, function, and identify underlying structural heart disease—particularly mitral valve pathology.

What It Means

A double-peaked or notched P wave occurs when the normally simultaneous right and left atrial activation peaks become separated in time. This separation reflects delayed left atrial activation, causing the right and left atrial electrical peaks to become distinct rather than fused 1. The term "left atrial abnormality" is preferred over older terms like "P mitrale," "left atrial enlargement," or "left atrial hypertrophy" because multiple pathophysiologic factors contribute: atrial dilatation, muscular hypertrophy, elevated atrial pressure, impaired ventricular compliance, and delayed intraatrial conduction 1.

Diagnostic Criteria

Look for these specific ECG features 1:

• P wave duration ≥120 ms (most important criterion)
• Widely notched P wave with ≥40 ms between peaks (the "double-peaked" appearance)
• P terminal force in V1: negative deflection with amplitude × duration product increased
• Left axis deviation of terminal P wave (30° to 90°)
• Purely negative P wave in V1 (suggestive but less specific)

The conduction delay typically occurs in Bachmann's bundle (the specialized interatrial pathway) and possibly within the left atrial myocardium itself 1.

Clinical Significance & Underlying Causes

Left atrial abnormality signals important cardiac pathology 2:

• Mitral valve disease (stenosis or regurgitation)—the classic association
• Left ventricular dysfunction with elevated filling pressures
• Hypertensive heart disease
• Cardiomyopathy with impaired ventricular compliance
• Atrial cardiomyopathy predisposing to atrial fibrillation

This finding independently predicts increased risk of atrial fibrillation, ischemic stroke, sudden cardiac death, and dementia 3.

Recommended Evaluation

Immediate Next Steps:

1. Transthoracic echocardiography (mandatory) 2:

   • Measure left atrial diameter and volume (indexed to height² in obese patients) 4
   • Assess mitral valve structure and function
   • Evaluate left ventricular systolic and diastolic function
   • Measure pulmonary artery pressures
   • Calculate LA/LVEDD ratio (≥0.80 suggests higher AF risk even without marked LA enlargement) 5

2. Assess left atrial function with speckle-tracking echocardiography when available:

   • LA reservoir strain
   • LA contractile strain <14% indicates dysfunction 4

3. Screen for atrial fibrillation:

   • Extended cardiac monitoring (Holter or event monitor)
   • Consider implantable loop recorder in cryptogenic stroke patients

Clinical Context Assessment:

• Symptoms: dyspnea, orthopnea, paroxysmal nocturnal dyspnea, palpitations, exercise intolerance
• Risk factors: hypertension, diabetes, chronic kidney disease (all associated with elevated LA/LVEDD ratio) 5
• CHA₂DS₂-VASc score for stroke risk stratification 5
• NT-proBNP levels (elevated in patients with LA abnormality and AF risk) 5

Management Implications

Treatment targets the underlying cause:

• Mitral valve disease: Consider valve repair/replacement based on severity and symptoms
• Hypertension: Aggressive blood pressure control to reduce LA pressure
• Heart failure: Optimize guideline-directed medical therapy to reduce filling pressures
• Atrial fibrillation prevention/management: Anticoagulation if AF detected; rhythm vs. rate control strategy

Critical Pitfalls to Avoid

1. Don't dismiss this finding as benign—it represents structural heart disease requiring investigation
2. Don't confuse with right atrial abnormality (tall, peaked P waves in lead II >2.5 mm without prolonged duration) 1
3. Don't rely on P wave duration alone—use multiple criteria for diagnosis 1
4. Don't assume LA enlargement without imaging—the ECG finding may precede anatomic enlargement 6
5. In obese patients (BMI ≥35), index LA volume to height² rather than BSA to avoid underdiagnosis 4

The double-peaked P wave is not merely an ECG curiosity—it's a red flag for significant cardiac pathology requiring systematic evaluation and management to prevent adverse outcomes including stroke and heart failure progression.